在淋巴瘤和多发性髓瘤患者中使用双特异性抗体
Adam Braun1, Sushanth Gouni2, Astrid Pulles3
1City of Hope National Medical Center, Duarte, CA.
概括
双特异性抗体 (BsAbs) 通过激活T细胞提供先进的癌症治疗,但可以引起诸如细胞因子释放综合征之类的毒性. 管理策略和更广泛的接入对于患者的利益至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 双特异性抗体 (BsAbs) 代表了癌症治疗的重大进展,特别是在血液性恶性瘤中.
- 它们的机制通常涉及T细胞激活,导致可预测的毒性,如细胞因子释放综合征 (CRS) 和免疫效应细胞相关的神经毒性综合征 (ICANS).
- 基于特定的抗原标和抗体设计,可能会产生独特的毒性,需要量身定制的管理协议.
研究的目的:
- 审查双特异抗体 (BsAbs) 的临床旅程.
- 阐明BsAbs.的常见毒性和管理策略.
- 检查新的药物和战略,以扩大在社区卫生保健机构获得BsAb治疗的机会.
主要方法:
- 关于双特异抗体的临床数据的文献综述.
- 对不良事件概况和管理准则的分析.
- 审查最近的FDA批准和新兴的治疗策略.
- 评估社区医疗整合面临的挑战和解决方案.
主要成果:
- 针对与CD20 (非霍奇金淋巴瘤) 相关的CD3+T细胞和BCMA或GPRC5D (多发性骨髓瘤) 的BsAbs已经改变了治疗范式.
- 常见的毒性包括CRS和ICANS,特定的BsAbs可能表现出独特的不良事件.
- 新型药物和三种特异性抗体正在出现,探索新的点和免疫细胞参与.
- 扩展到社区实践需要教育,运营和协作努力.
结论:
- 有效管理与BsAb相关的毒性对于患者安全和治疗成功至关重要.
- 新型BsAbs和相关结构的持续开发有望提高有效性和安全性.
- 在社区环境中扩大BsAb治疗的机会至关重要,以确保患者从这些变革性癌症治疗中获得公平的益处.
相关概念视频
01:31Hybridoma Technology
14.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.4K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
510
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
510